Get access

Hypereosinophilic syndrome in an atopic patient

Authors


  • Conflict of interest: none declared.

Dr Sabine Neve, Department of Dermatology, VU University Medical Centre, De Boelelaan 1117, 1007 MB Amsterdam, The Netherlands
E-mail: s.neve@vumc.nl

Summary

Hypereosinophilic syndrome (HES) is a rare, heterogeneous group of systemic diseases characterized by sustained overproduction of eosinophils leading to variable end-organ damage. The skin is affected in 45–60% of patients and may be of diagnostic and prognostic value. In 1975, three criteria were suggested for the diagnosis of HES: (i) blood eosinophilia of > 1.5 × 109/L present for > 6 months, (ii) no apparent cause for the hypereosinophilia, and (iii) signs of end-organ dysfunction. We present a patient with hypereosinophilia in whom a delay in diagnosing HES occurred, partly due to his atopic constitution. However, atopy is not associated with such high or longstanding eosinophilia.

Get access to the full text of this article

Ancillary